Zelegent, Inc. Launches Multi-Center Snoring Reduction Trial

Zelegent, Inc., a clinical-stage medical technology company developing innovative tools for otolaryngologist sleep specialists, today announced the beginning of enrollment in its multi-center pivotal snoring reduction trial, the S.I.LE.N.C.E. study.

Read More

Zelegent, Inc. Pilot Study Results Show Significant Improvement in All Study Endpoints

Zelegent, Inc. presented clinical outcomes from its pilot clinical study today at the 3rd Congress of European Otorhinolaryngology and Head and Neck Surgery (ORL-HNS) in Prague, Czech Republic.

Read More

Zelegent Appoints Clinical Advisory Board, Joins Incubator & Will Unveil Study Results Next Week

Zelegent, Inc. announced today that five experts in sleep disorder therapy have joined its clinical advisory board, the company has joined the EvoNexus incubator program, and the company plans to present results from its first clinical trial next week.

Read More

Snorx, Inc. Changes Name to Zelegent, Inc.

Snorx, Inc. today reported that the Company’s Board of Directors has voted to change the name of the Company to Zelegent, Inc.

Read More

Snorx, Inc. Taps Medical Technology Industry Veteran Alexander K. Arrow, MD as Chief Executive Officer

Snorx, Inc. today reported that Alexander K. Arrow, M.D. has been appointed Chief Executive Officer and will be leading the company as it enters its regulatory submission phase and prepares to manufacture its first product.

Read More